TY - JOUR
T1 - Affibody-Indocyanine Green Based Contrast Agent for Photoacoustic and Fluorescence Molecular Imaging of B7-H3 Expression in Breast Cancer
AU - Bam, Rakesh
AU - Laffey, Makenna
AU - Nottberg, Katharine
AU - Lown, Patrick S.
AU - Hackel, Benjamin J.
AU - Wilson, Katheryne E.
N1 - Publisher Copyright:
© 2019 American Chemical Society.
PY - 2019/6/19
Y1 - 2019/6/19
N2 - Spectroscopic photoacoustic (sPA) molecular imaging has high potential for identification of exogenous contrast agents targeted to specific markers. Antibody-dye conjugates have recently been used extensively for preclinical sPA and other optical imaging modalities for highly specific molecular imaging of breast cancer. However, antibody-based agents suffer from long circulation times that limit image specificity. Here, the efficacy of a small protein scaffold, the affibody (ABY), conjugated to indocyanine green (ICG), a near-infrared fluorescence dye, as a targeted molecular imaging probe is demonstrated. In particular, B7-H3 (CD276), a cellular receptor expressed in breast cancer, was imaged via sPA and fluorescence molecular imaging to differentiate invasive tumors from normal glands in mice. Administration of ICG conjugated to an ABY specific to B7-H3 (ABYB7-H3-ICG) showed significantly higher signal in mammary tumors compared to normal glands of mice. ABYB7-H3-ICG is a compelling scaffold for molecular sPA imaging for breast cancer detection.
AB - Spectroscopic photoacoustic (sPA) molecular imaging has high potential for identification of exogenous contrast agents targeted to specific markers. Antibody-dye conjugates have recently been used extensively for preclinical sPA and other optical imaging modalities for highly specific molecular imaging of breast cancer. However, antibody-based agents suffer from long circulation times that limit image specificity. Here, the efficacy of a small protein scaffold, the affibody (ABY), conjugated to indocyanine green (ICG), a near-infrared fluorescence dye, as a targeted molecular imaging probe is demonstrated. In particular, B7-H3 (CD276), a cellular receptor expressed in breast cancer, was imaged via sPA and fluorescence molecular imaging to differentiate invasive tumors from normal glands in mice. Administration of ICG conjugated to an ABY specific to B7-H3 (ABYB7-H3-ICG) showed significantly higher signal in mammary tumors compared to normal glands of mice. ABYB7-H3-ICG is a compelling scaffold for molecular sPA imaging for breast cancer detection.
UR - http://www.scopus.com/inward/record.url?scp=85066397952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066397952&partnerID=8YFLogxK
U2 - 10.1021/acs.bioconjchem.9b00239
DO - 10.1021/acs.bioconjchem.9b00239
M3 - Article
C2 - 31082216
AN - SCOPUS:85066397952
SN - 1043-1802
VL - 30
SP - 1677
EP - 1689
JO - Bioconjugate Chemistry
JF - Bioconjugate Chemistry
IS - 6
ER -